ROIV News and Press, Roivant Sciences Ltd. From 11/10/25

BASEL, Switzerland and LONDON and NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today reported its financial results for the second quarter ended September 30, 2025, and provided a business update. Brepocitinib 30 mg demonstrated clinically meaningful and statistic...

VEON Ltd. (VEON) is expected to report $1.21 for Q3 2025 eToro Group Ltd. (ETOR) is expected to report $0.52 for Q3 2025 KE Holdings Inc American Depositary Shares (each representing three Class A) (BEKE) is expected to report $0.09 for Q3 2025 CoreWeave Inc. (CRWV) is expected to rep...

2025-11-07 10:35:47 ET More on Roivant Sciences Roivant Sciences Ltd. (ROIV) Presents at Bernstein 2nd Annual Global Healthcare Conference Transcript Roivant Sciences Ltd. (ROIV) Presents at Bank of America Global Healthcare Conference 2025 Transcript Roivant Science...

2025-11-02 22:05:00 ET With just two months left in the year, it's time to update our asset class performance matrix and highlight the best- and worst-performing stocks year-to-date.... Read the full article on Seeking Alpha For further details see: ...

2025-10-30 10:04:09 ET More on Immunovant Seeking Alpha’s Quant Rating on Immunovant Historical earnings data for Immunovant Financial information for Immunovant Read the full article on Seeking Alpha For further details see: Immunovant gai...

2025-10-28 14:19:00 ET More on Baron Health Care Fund Retail Shares Baron Health Care Fund Q3 2025 Shareholder Letter Read the full article on Seeking Alpha For further details see: Baron Health Care Fund buys ABBV, UNH, ROIV; exits WAT and COO

BASEL, Switzerland and LONDON and NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Monday, November 10, 2025, to report its financial results for the second quarter ended September 30, 2025, ...

NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Immunovant (Nasdaq: IMVT) today announced that it will report its financial results for the second quarter ended September 30, 2025, and provide a business update at 8:00 a.m. ET on Monday, November 10, 2025. To access the Roivant (Nasdaq: ROIV) con...

2025-10-21 14:04:26 ET DFAS strategy Dimensional U.S. Small Cap ETF ( DFAS ) is an actively managed fund launched on 12/15/1998 as a mutual fund and listed as an ETF on 6/14/2021. Historical prices are available at data providers from the latter date. DFAS has a portfolio of 2,0...

2025-10-03 16:38:09 ET More on Roivant Sciences Roivant Sciences Ltd. (ROIV) Presents at Bernstein 2nd Annual Global Healthcare Conference Transcript Roivant Sciences Ltd. (ROIV) Presents at Bank of America Global Healthcare Conference 2025 Transcript Roivant Science...